Archive

It has been little more than a decade since researchers categorized the full suite of genes contained in the human body, but this exciting milestone merely opened up an even more challenging frontier. There turns out to be only about 20,000 genes associated with the famous DNA molecule—a sizable

A renowned cardiac surgeon, a champion of innovation, and an experienced and respected administrator, Dr. Thierry Mesana is also a passionate advocate for the University of Ottawa Heart Institute. On September 11, the Heart Institute announced his appointment as its third President and CEO, to

Since the initial proposal was developed in 2004, the road to expansion for the University of Ottawa Heart Institute has been a long one. The Province of Ontario announcement in August 2011 of funding to expand and update facilities at the Heart Institute had been greatly anticipated. Since the

Few health challenges are as well-publicized as high blood pressure, a topic that has become all too familiar, appearing everywhere from the daily news to medical conferences. And being so familiar, it is easy to overlook the fact that most of this attention has been devoted to a problem that stems

Like most health care organizations in Canada, the University of Ottawa Heart Institute undergoes regular review by Accreditation Canada. This rigorous process assesses hospitals against more than 900 standards and criteria. As part of its 2013 accreditation, Accreditation Canada identified four

This year, the Canadian Cardiovascular Congress is part of an even larger event called Vascular 2013, combining parallel conferences dedicated to cardiovascular disease, hypertension, diabetes and stroke. The University of Ottawa Heart Institute has program items in all of these—nearly 120 in all

In July, the first patient in a landmark clinical trial received treatment at the University of Ottawa Heart Institute. The new ENACT-AMI (Enhanced Angiogenic Cell Therapy—Acute Myocardial Infarction) trial, led by the Ottawa Hospital Research Institute, is designed to test whether genetically

This year, the Canadian Cardiovascular Congress (CCC) was part of an even larger event called Vascular 2013 that added parallel conferences dedicated to hypertension, diabetes and stroke. The University of Ottawa Heart Institute had program items in all of these subject areas— nearly 120 in all

The American Heart Association Scientific Sessions is the largest conference for cardiovascular science and medicine in the world. The staff of the University of Ottawa Heart Institute is once again responsible for many expert clinical talks and research presentations. This guide highlights those

Diabetes is a major contributing factor for heart disease. Diabetes patients are two to three times more likely to develop cardiovascular disease than the general population. With the condition widely undertreated and diabetes rates growing, cardiovascular professionals are looking to stem the flow